FDA Approves First Gene Therapy for Severe LAD-1

by | Mar 27, 2026 | Health

Spread the love
Marne-cel now offers an option to children with the rare immune disorder who lack a sibling donor for stem cell transplantation.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments